Literature DB >> 7575522

Differential expression of cytokine genes in cervical cancer tissues.

C C Pao1, C Y Lin, D S Yao, C J Tseng.   

Abstract

The expression of genes coding for inflammatory cytokine interleukin-1-alpha (IL-1 alpha), IL-6, interferon-gamma and tumor necrosis factor-alpha from 15 normal cervix, 11 cervical intraepithelial neoplasia and 13 cervical cancer tissues was investigated. The cytokine messenger ribonucleic acids were reverse transcribed and amplified in the presence of biotinylated and dinitrophenylated primers. Amplified DNA was then captured onto streptavidin-coated microwell plate and quantitatively measured in a colorimetric reaction using ant-DNP antibodies conjugated to horse radish peroxidase. There is no change of IL-1 alpha, IL-6 and tumor necrosis factor-alpha gene expression in either cervical intraepithelial neoplasia or cervical cancer tissues. But the transcription of interferon-gamma gene is significantly reduced in both cervical intraepithelial neoplasia and cervical cancer tissue as compared to normal cervix. This study demonstrated that reverse transcription and quantitative polymerase chain reaction coupling to colorimetric microwell plate assay is a sensitive and useful method to quantitate multiple cytokine gene expression. Our results also suggest that cervical epithelial cells are capable to express cytokines and that interferon-gamma may play a role in the pathogenesis of cervical cancer since its reduced expression may influence inflammation and immunity of the cervical tissues.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7575522     DOI: 10.1006/bbrc.1995.2405

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

Review 1.  Cell-mediated immune response to human papillomavirus infection.

Authors:  M Scott; M Nakagawa; A B Moscicki
Journal:  Clin Diagn Lab Immunol       Date:  2001-03

2.  Cervical cancer and CYP2E1 polymorphisms: implications for molecular epidemiology.

Authors:  Paula M Ferreira; Raquel Catarino; Deolinda Pereira; Ana Matos; Daniela Pinto; Ana Coelho; Carlos Lopes; Rui Medeiros
Journal:  Eur J Clin Pharmacol       Date:  2005-12-22       Impact factor: 2.953

3.  Characterization of colorectal-cancer-related cDNA clones obtained by subtractive hybridization screening.

Authors:  J Cao; X Cai; L Zheng; L Geng; Z Shi; C C Pao; S Zheng
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

4.  Solubilized antigen of Blastocystis hominis facilitates the growth of human colorectal cancer cells, HCT116.

Authors:  Samudi Chandramathi; Kumar Suresh; Umah Rani Kuppusamy
Journal:  Parasitol Res       Date:  2010-02-18       Impact factor: 2.289

5.  Toll-like receptor transcriptome in the HPV-positive cervical cancer microenvironment.

Authors:  Correne A DeCarlo; Bruce Rosa; Robert Jackson; Sarah Niccoli; Nicholas G Escott; Ingeborg Zehbe
Journal:  Clin Dev Immunol       Date:  2011-10-13

6.  Seminal plasma induces the expression of IL-1α in normal and neoplastic cervical cells via EP2/EGFR/PI3K/AKT pathway.

Authors:  Anthonio O Adefuye; Kurt J Sales; Arieh A Katz
Journal:  J Mol Signal       Date:  2014-08-08

7.  Differential expression of cytokines and receptor expression during anoxic growth.

Authors:  Balbina J Plotkin; Ira M Sigar; Julie A Swartzendruber; Amber Kaminski; James Davis
Journal:  BMC Res Notes       Date:  2018-06-25

Review 8.  Papillomavirus Immune Evasion Strategies Target the Infected Cell and the Local Immune System.

Authors:  Chenhao Zhou; Zewen Kelvin Tuong; Ian Hector Frazer
Journal:  Front Oncol       Date:  2019-08-02       Impact factor: 6.244

Review 9.  Gut Helminth Infection-Induced Immunotolerance and Consequences for Human Papillomavirus Persistence.

Authors:  Eva H Clark; Robert H Gilman; Elizabeth Y Chiao; Patti E Gravitt
Journal:  Am J Trop Med Hyg       Date:  2021-07-19       Impact factor: 3.707

10.  Ustekinumab-associated disseminated verrucae.

Authors:  Mary E Anderson; Dawn Queen; Stephen L Vance; Larisa J Geskin
Journal:  JAAD Case Rep       Date:  2018-11-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.